3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID
- Product Name
- 3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID
- CAS No.
- 115664-39-6
- Chemical Name
- 3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID
- Synonyms
- 3-Carboxy DetoMidine;Detomidine carboxylic acid;detomidine 3-carboxylic acid;3-(1H-IMidazol-5-ylMethyl)-2-Methylbenzoic Acid;3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID;Benzoic acid, 3-(1H-imidazol-5-ylmethyl)-2-methyl-
- CBNumber
- CB9840865
- Molecular Formula
- C12H12N2O2
- Formula Weight
- 216.24
- MOL File
- 115664-39-6.mol
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID Property
- Boiling point:
- 499.6±33.0 °C(Predicted)
- Density
- 1.278±0.06 g/cm3(Predicted)
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- 3.83±0.10(Predicted)
- form
- Solid
- color
- White to Pale Brown
N-Bromosuccinimide Price
- Product number
- C177915
- Product name
- 3-CarboxyDetomidine
- Packaging
- 10mg
- Price
- $350
- Updated
- 2021/12/16
- Product number
- 0941CB
- Product name
- 3-(1H-Imidazol-4-ylmethyl)-2-methylbenzoicacid
- Packaging
- 2mg
- Price
- $387
- Updated
- 2021/12/16
- Product number
- CHM0372228
- Product name
- 3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $504.93
- Updated
- 2021/12/16
- Product number
- MTB0002277
- Product name
- 3-CARBOXY DETOMIDINE
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $505.69
- Updated
- 2021/12/16
- Product number
- FC19731
- Product name
- 3-Carboxy detomidine
- Packaging
- 10mg
- Price
- $520
- Updated
- 2021/12/16
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID Chemical Properties,Usage,Production
Chemical Properties
Off-White Solid
Uses
The major metabolite of the drug Detomidine.
in vivo
Horse urine is investigated for metabolites following the oral administration of the large animal analgesic sedative Detomidine to two stallions and intravenous administration of [3H]-Detomidine to a mare. Detomidine carboxylic acid and hydroxydetomidine glucuronic acid conjugate are identified in the urine after the oral doses. About half of the radioactivity of [3H]-Detomidine is excreted in the urine in 12 h after the i.v. dose (80 μg/kg). Most of the excretion occurred between 5 and 12 h in contrast to urine output which is highest 2-5 h after the dosing. The major radioactive metabolite in the urine is Detomidine carboxylic acid. Detomidine carboxylic acid comprises more than two thirds of the total metabolites in all the urine fractions collected[1].
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID Preparation Products And Raw materials
Raw materials
Preparation Products
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID Suppliers
- Tel
- --
- Fax
- --
- @pharmaffiliates.com
- Country
- India
- ProdList
- 6754
- Advantage
- 58
- Tel
- --
- Fax
- --
- mktg@pharmaffiliates.com
- Country
- India
- ProdList
- 6739
- Advantage
- 58